Home › Funds › Equitable › Multimanager Aggressive Equity Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044691
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 7,870 with, 209 against, 31 abstentions (not counted as with management); 6 items carried no recommendation; 104 split votes are in neither count. Shareholder proposals: 62 FOR, 122 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 85.1% | 7,725 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | 10.7% | 84 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 750 items (9.5% of the 7,925 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Dayforce, Inc. | 2025-11-12 | A proposal to adopt the Agreement and Plan of Merger, dated as of August 20, 2025 (the "merger agreement"), by and among Dayforce, Inc. ("Dayforce"), Dawn Bidco, LLC and Dawn Acquisition Merger Sub, Inc. | Against | FOR — 22 of 22 Equitable funds | Against | Approved, 88.4% support |
| Dayforce, Inc. | 2025-11-12 | A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to adopt the merger agreement. | Against | FOR — 22 of 22 Equitable funds | Against | — |
| Dayforce, Inc. | 2025-11-12 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Dayforce's named executive officers in connection with the transactions contemplated by the merger agreement, including consummation of the merger. | Against | FOR — 22 of 22 Equitable funds | Against | — |
| Morgan Stanley | 2026-05-14 | Shareholder Shareholder proposal requesting an independent Board Chairman | For | AGAINST — 16 of 17 Equitable funds | Against | Failed (calculated), 27.3% support |
| T-Mobile US, Inc. | 2026-06-16 | Advisory Vote to Approve the Compensation Provided to the Company's Named Executive Officers for 2025. | For | AGAINST — 15 of 17 Equitable funds | For | Approved, 73.3% support |
| T-Mobile US, Inc. | 2026-06-16 | Election of Directors: Christian P. Illek | For | WITHHOLD — 12 of 16 Equitable funds | For | Passed (calculated), 78.9% support |
| T-Mobile US, Inc. | 2026-06-16 | Election of Directors: Dominique Leroy | For | WITHHOLD — 12 of 16 Equitable funds | For | Passed (calculated), 78.3% support |
| T-Mobile US, Inc. | 2026-06-16 | Election of Directors: Raphael Kubler | For | WITHHOLD — 12 of 16 Equitable funds | For | Passed (calculated), 78.3% support |
| Astera Labs, Inc. | 2026-06-04 | To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Michael Hurlston | For | WITHHOLD — 4 of 4 Equitable funds | Against | Elected, 68.3% support |
| Roku, Inc. | 2026-06-11 | To elect three Class III directors to serve until the 2029 Annual Meeting of Stockholders: Jeffrey Hastings | For | WITHHOLD — 6 of 7 Equitable funds | Against | Passed (calculated), 83.8% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden | Withhold | FOR — 8 of 10 Equitable funds | Against | Passed (calculated), 98.8% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | Withhold | FOR — 8 of 10 Equitable funds | Against | Passed (calculated), 85.5% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Stephen Gillett | For | AGAINST — 6 of 7 Equitable funds | Against | Elected, 92.0% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 6 of 7 Equitable funds | Against | Elected, 91.7% support |
| CompoSecure, Inc. | 2025-12-23 | To approve the issuance of CompoSecure's Class A Common Stock, par value $0.0001 per share, in connection with the transactions contemplated by, and pursuant to the terms of, the Share Purchase Agreement (as it may be amended from time to time, the "Transaction Agreement") that we and certain of our | Abstain | FOR — 6 of 7 Equitable funds | Against | Approved, 100.0% support |
| Amylyx Pharmaceuticals, Inc. | 2026-06-04 | Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mc | Withhold | FOR — 6 of 7 Equitable funds | Against | Passed (calculated), 84.5% support |
| Amylyx Pharmaceuticals, Inc. | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 6 of 7 Equitable funds | Against | Approved, 85.2% support |
| Palvella Therapeutics, Inc. | 2026-06-10 | Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. | Against | FOR — 6 of 7 Equitable funds | Against | — |
| Palvella Therapeutics, Inc. | 2026-06-10 | Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. Davis | Withhold | FOR — 6 of 7 Equitable funds | Against | Passed (calculated), 81.8% support |
| Nuvation Bio Inc. | 2026-05-21 | Election of Directors: Robert Bazemore | Withhold | FOR — 6 of 7 Equitable funds | Against | Elected, 84.0% support |
| Nuvation Bio Inc. | 2026-05-21 | Election of Directors: Robert Mashal, M.D. | Withhold | FOR — 6 of 7 Equitable funds | Against | Elected, 92.1% support |
| OneSpan Inc. | 2026-06-05 | To elect seven directors to serve on the Board of Directors: Michael McConnell | Against | FOR — 6 of 7 Equitable funds | Against | Elected, 81.6% support |
| International Money Express, Inc. | 2025-12-09 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intermex's named executive officers that is based on or otherwise relates to the Merger Agreement and/or the transactions contemplated by the Merger Agreement. | Against | FOR — 6 of 7 Equitable funds | Against | Approved, 75.1% support |
| WK Kellogg Co. | 2025-09-19 | The Adjournment Proposal - To approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the special meeting to approve the Merger Proposal. | Abstain | FOR — 6 of 7 Equitable funds | Against | — |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Charles R. Crisp | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 96.4% support |
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Laura C. Fulton | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 87.2% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Paul W. Chung | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 94.0% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: R. Keith Teague | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 96.9% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. Morris | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 83.9% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris Cain | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 86.8% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd Shegog | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 86.7% support |
| Snowflake Inc. | 2025-07-02 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 5 of 6 Equitable funds | Against | Not approved, 30.2% support |
| Spyre Therapeutics, Inc. | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Mark McKenna | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 98.0% support |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. Lance | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 76.9% support |
| Enliven Therapeutics, Inc. | 2026-06-09 | To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 64.7% support |
| Legence Corp. | 2026-06-11 | Election of Directors: Bilal Khan | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 78.6% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Fay West | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 97.5% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Jeffry D. Frisby | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 99.3% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Linda G. O'Brien | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 83.5% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Mark Moran | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 76.2% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Neil Y. Kim | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 99.4% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Peter J. Gundermann | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 98.9% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Robert S. Keane | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 78.6% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Robert T. Brady | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 93.1% support |
| Astronics Corporation | 2026-05-28 | To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Warren C. Johnson | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 83.6% support |
| Ardent Health, Inc. | 2026-05-20 | Election of Directors: Peter Bynoe | For | WITHHOLD — 5 of 6 Equitable funds | For | Passed (calculated), 95.2% support |
| Immunome, Inc. | 2026-06-09 | To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James Boylan | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 76.0% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Elaine S. Yatzkan | Against | FOR — 5 of 6 Equitable funds | Against | Elected, 91.4% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Howard S. Jonas | Against | FOR — 5 of 6 Equitable funds | Against | Elected, 89.8% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Irwin Katsof | Against | FOR — 5 of 6 Equitable funds | Against | Elected, 90.9% support |
| IDT Corporation | 2025-12-11 | Election of Directors: Judah Schorr | Against | FOR — 5 of 6 Equitable funds | Against | Elected, 88.0% support |
| Maze Therapeutics, Inc. | 2026-06-08 | Election of Class I Directors: Neil Kumar, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 81.6% support |
| Triumph Financial, Inc. | 2026-04-23 | Management Proposal Regarding Advisory Approval of the Company's Executive Compensation | Against | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 70.9% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Priya Patil | For | AGAINST — 5 of 6 Equitable funds | For | Passed (calculated), 80.1% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Russell Ball | Against | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 97.4% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Sofia Bianchi | Against | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 89.8% support |
| Metsera, Inc. | 2025-11-13 | To adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. | Abstain | FOR — 5 of 6 Equitable funds | Against | — |
| Metsera, Inc. | 2025-11-13 | To adopt the Agreement and Plan of Merger, dated as of September 21, 2025 (as it may be amended from time to time, the "Merger Agreement"), by and among Pfizer Inc., a Delaware corporation ("Parent"), Mayfair Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger S | Abstain | FOR — 5 of 6 Equitable funds | Against | Approved, 100.0% support |
| Sionna Therapeutics, Inc. | 2026-06-17 | To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Peter A. Thompson, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| Phillips 66 | 2026-05-13 | Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Gregory J. Hayes | Against | FOR — 13 of 21 Equitable funds | Against | Passed (calculated), 91.2% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: Mark J. Hawkins | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 93.4% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: Rhonda J. Morris | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.3% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Carl Vogel | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Chad Hollingsworth | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 94.9% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James Iovine | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.4% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James S. Kahan | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Jeffrey T. Hinson | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.6% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Latriece Watkins | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.4% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Ping Fu | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.6% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Randall T. Mays | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 97.0% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. Grenell | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. Paul | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.7% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To hold an advisory vote on the company's executive compensation; | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 86.8% support |
| Tractor Supply Company | 2026-05-14 | To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay) | Against | FOR — 12 of 19 Equitable funds | Against | Approved, 86.0% support |
| Entegris, Inc. | 2026-05-06 | Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. | Against | FOR — 6 of 8 Equitable funds | Against | Failed (calculated), 31.3% support |
| Entegris, Inc. | 2026-05-06 | To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders. | For | AGAINST — 6 of 8 Equitable funds | Against | Passed (calculated), 83.6% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Advisory vote to approve the compensation of our named executive officers. | Against | FOR — 6 of 8 Equitable funds | Against | — |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Frances H. Arnold | Against | FOR — 14 of 24 Equitable funds | Against | Elected, 90.1% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan. | Against | FOR — 13 of 22 Equitable funds | Against | Approved, 79.1% support |
| T-Mobile US, Inc. | 2026-06-16 | Election of Directors: G. Michael Sievert | For | WITHHOLD — 10 of 16 Equitable funds | For | Passed (calculated), 90.2% support |
| The Charles Schwab Corporation | 2026-05-21 | Election of directors for three-year terms: Frank C. Herringer | Against | FOR — 13 of 22 Equitable funds | Against | Elected, 84.3% support |
| Adobe Inc. | 2026-04-15 | Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Frank Calderoni | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 88.6% support |
| Carvana Co. | 2026-05-05 | Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement. | For | AGAINST — 10 of 16 Equitable funds | Against | Not approved, 3.9% support |
| DoorDash, Inc. | 2026-06-10 | The election of the following director nominee(s): Shona L. Brown | Against | FOR — 10 of 16 Equitable funds | Against | Elected, 89.8% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: George J. Still, Jr. | Against | FOR — 11 of 18 Equitable funds | Against | Elected, 97.0% support |
| Zoetis Inc. | 2026-05-20 | Shareholder Shareholder proposal to permit shareholder action by written consent. | For | AGAINST — 12 of 20 Equitable funds | Against | — |
| Corpay, Inc. | 2026-05-07 | Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. | For | AGAINST — 10 of 16 Equitable funds | Against | Failed (calculated), 30.0% support |
| FactSet Research Systems Inc. | 2025-12-18 | To approve the FactSet Research Systems Inc. 2025 Omnibus Incentive Plan. | Against | FOR — 12 of 20 Equitable funds | Against | — |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 94.1% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.2% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.2% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.1% support |
| Lennox International Inc. | 2026-05-21 | To elect three Class I directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Karen H. Quintos | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 93.2% support |
| Xometry, Inc. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Roy Azevedo | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.7% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Amy Boerger | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 99.2% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Dr. Kennon H. Guglielmo | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 78.3% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Michael J. McRoberts | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 99.6% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Raymond J. Chess | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 77.9% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Thomas A. Akin | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.8% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Troy A. Clarke | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 78.3% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: W. M. Rusty Rush | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 99.3% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: William H. Cary | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 99.0% support |
| Alliance Laundry Holdings Inc. | 2026-06-11 | To elect Michael D. Schoeb, Phyllis A. Knight and Robert L. Verigan as Class I directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert L. Verigan | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Adaptive Biotechnologies Corporation | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Interparfums, Inc. | 2025-09-10 | Election of Directors: Robert Bensoussan | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 94.8% support |
| Interparfums, Inc. | 2025-09-10 | Election of Directors: Veronique Gabai-Pinsky | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.4% support |
| Pulse Biosciences, Inc. | 2025-12-09 | Election of Directors: Manmeet S. Soni | Abstain | FOR — 4 of 5 Equitable funds | Against | Elected, 99.5% support |
| Pulse Biosciences, Inc. | 2025-12-09 | Election of Directors: Robert W. Duggan | Abstain | FOR — 4 of 5 Equitable funds | Against | Elected, 97.5% support |
| The Vita Coco Company, Inc. | 2026-06-03 | Election of Class II Directors: Kenneth Sadowsky | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 80.8% support |
| Nicolet Bankshares, Inc. | 2026-05-18 | Approval, on a non-binding advisory basis, of the compensation paid to Nicolet's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 67.1% support |
| Nicolet Bankshares, Inc. | 2026-05-18 | NOMINEES: John N. Dykema | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 91.0% support |
| Dave Inc. | 2026-06-02 | Director Election: Dan Preston | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 86.4% support |
| American States Water Company | 2026-05-19 | Election of Class III Directors: Mr. C. James Levin | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 94.9% support |
| American States Water Company | 2026-05-19 | Election of Class III Directors: Mr. Roger M. Ervin | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.7% support |
| American States Water Company | 2026-05-19 | Election of Class III Directors: Mr. Thomas A. Eichelberger | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.8% support |
| Warby Parker Inc. | 2026-06-08 | Election of Directors: David ("Dave") Gilboa | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 98.9% support |
| Warby Parker Inc. | 2026-06-08 | Election of Directors: Ronald Williams | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 91.5% support |
| Warby Parker Inc. | 2026-06-08 | Election of Directors: Youngme Moon | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.3% support |
| SiriusPoint Ltd. | 2026-05-20 | Election of two Class 1 director nominees for 3-year terms expiring in 2029: Susan L. Cross | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 97.3% support |
| MGE Energy, Inc. | 2026-05-19 | Election of Class I Directors: Angela S. Rieger | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.5% support |
| MGE Energy, Inc. | 2026-05-19 | Election of Class I Directors: James G. Berbee | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| MGE Energy, Inc. | 2026-05-19 | Election of Class I Directors: Londa J. Dewey | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.9% support |
| Constellium SE | 2026-05-21 | Re-appointment of Mr. John Ormerod as a director for a term of three years | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 83.8% support |
| USA Rare Earth, Inc. | 2026-06-03 | Election of Directors: Carolyn Trabuco | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 86.1% support |
| USA Rare Earth, Inc. | 2026-06-03 | Election of Directors: Michael Blitzer | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 85.1% support |
| NovaGold Resources Inc. | 2026-05-14 | Approval of Non-Binding Advisory Vote on Executive Compensation To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 72.5% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Daniel Muniz Quintanilla | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 91.4% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Dawn Whittaker | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.5% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Dr. Elaine Dorward-King | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 91.5% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Dr. Thomas Kaplan | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.1% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Ethan Schutt | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.3% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Hume Kyle | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 98.8% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Kalidas Madhavpeddi | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 88.8% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Kevin McArthur | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.5% support |
| Grindr Inc. | 2025-07-30 | Election of Directors: J. Michael Gearon, Jr. | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.7% support |
| Grindr Inc. | 2025-07-30 | Election of Directors: James Fu Bin Lu | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.6% support |
| Grindr Inc. | 2025-07-30 | Election of Directors: Meghan Stabler | For | WITHHOLD — 4 of 5 Equitable funds | For | Elected, 93.8% support |
| Grindr Inc. | 2025-07-30 | Election of Directors: Nathan Richardson | For | WITHHOLD — 4 of 5 Equitable funds | For | Elected, 93.8% support |
| Ouster, Inc. | 2026-06-17 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 79.9% support |
| Pitney Bowes Inc. | 2026-05-12 | Election of Directors: Wayne Walker | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 91.6% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: B. Scott Smith | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.3% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: David Bruton Smith | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.3% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: Jeff Dyke | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.8% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: Keri A. Kaiser | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 92.1% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: Marcus G. Smith | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.3% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: Michael Hodge | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.3% support |
| Sonic Automotive, Inc. | 2026-04-29 | Election of Directors: William R. Brooks | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.0% support |
| Innospec Inc. | 2026-05-08 | Election of two Class I Directors: Claudia P. Poccia | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.4% support |
| Innospec Inc. | 2026-05-08 | Election of two Class I Directors: Elizabeth K. Arnold | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 91.4% support |
| Trevi Therapeutics, Inc. | 2026-06-03 | Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders: Michael Heffernan | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Kaiser Aluminum Corporation | 2026-06-04 | Election of Directors: BRETT E. WILCOX | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.1% support |
| Kaiser Aluminum Corporation | 2026-06-04 | Election of Directors: GLENDA J. MINOR | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.1% support |
| Pathward Financial, Inc. | 2026-02-24 | Election of Directors: Christopher Perretta | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 94.1% support |
| Pathward Financial, Inc. | 2026-02-24 | Election of Directors: Douglas J. Hajek | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.6% support |
| Pathward Financial, Inc. | 2026-02-24 | Election of Directors: Kendall E. Stork | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.9% support |
| Mineralys Therapeutics, Inc. | 2026-05-21 | Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. | For | WITHHOLD — 4 of 5 Equitable funds | For | Passed (calculated), 63.3% support |
| Taysha Gene Therapies, Inc. | 2026-06-01 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 82.2% support |
| Sylvamo Corporation | 2026-05-15 | Elect the seven director nominees named in the proxy statement to our Board of Directors: David Petratis | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 92.7% support |
| Middlesex Water Company | 2026-05-19 | Election of Directors: James F. Cosgrove, Jr. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.3% support |
| Middlesex Water Company | 2026-05-19 | Election of Directors: Joshua Bershad, MD | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.1% support |
| Middlesex Water Company | 2026-05-19 | Election of Directors: Vaughn L. McKoy | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 79.7% support |
| Amprius Technologies, Inc. | 2026-06-11 | Election of Class I Directors: Kathleen Bayless | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 71.4% support |
| IRadimed Corporation | 2026-06-23 | Election of Directors: Monty Allen | For | WITHHOLD — 4 of 5 Equitable funds | For | Elected, 87.3% support |
| Fluence Energy, Inc. | 2026-03-12 | To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Fahad Al-Darwish | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.8% support |
| Fluence Energy, Inc. | 2026-03-12 | To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: John Christopher ("Chris") Shelton | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Fluence Energy, Inc. | 2026-03-12 | To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Peter Chi-Shun Luk | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.8% support |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | Election of Directors: Michael A. Metzger | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 98.9% support |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | Election of Directors: Pierre Legault | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 63.5% support |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Atlas Energy Solutions Inc. | 2026-05-07 | Election to the Company's Board of Directors of the two Class III directors set forth in the accompanying proxy statement, each of whom will hold office until the 2029 Annual Meeting of Stockholders and until their successor is elected and qualified or until their earlier death, resignation or remov | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 88.5% support |
| Priority Technology Holdings, Inc. | 2026-06-11 | Election of Directors: Marc Crisafulli | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 99.0% support |
| Priority Technology Holdings, Inc. | 2026-06-11 | Election of Directors: Michael Passilla | For | AGAINST — 4 of 5 Equitable funds | For | Elected, 98.2% support |
| Camping World Holdings, Inc. | 2026-05-21 | Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.0% support |
| Camping World Holdings, Inc. | 2026-05-21 | Election of Class I Directors: K. Dillon Schickli | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 93.0% support |
| Camping World Holdings, Inc. | 2026-05-21 | Election of Class I Directors: Mary J. George | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.8% support |
| Capricor Therapeutics, Inc. | 2026-06-04 | ELECTION OF DIRECTORS: Frank Litvack | For | WITHHOLD — 4 of 5 Equitable funds | For | Passed (calculated), 68.6% support |
| Build-A-Bear Workshop, Inc. | 2026-06-11 | Election of Directors: Lesli Rotenberg | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 93.1% support |
| Build-A-Bear Workshop, Inc. | 2026-06-11 | Election of Directors: Narayan Iyengar | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 95.9% support |
| Gogo Inc. | 2026-05-28 | Advisory vote approving executive compensation | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 91.9% support |
| Avadel Pharmaceuticals plc | 2026-01-12 | Ordinary resolution to approve any motion by the Chair to adjourn the Extraordinary General Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to ap | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Avadel Pharmaceuticals plc | 2026-01-12 | Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel") to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Avadel Pharmaceuticals plc | 2026-01-12 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 86.4% support |
| Avadel Pharmaceuticals plc | 2026-01-12 | Special resolution to approve an amendment to the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes plc or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Avadel Pharmaceuticals Plc | 2026-01-12 | That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to. | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Avadel Pharmaceuticals Plc | 2026-01-12 | That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved. | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| CECO Environmental Corp. | 2026-05-27 | Adjournment Proposal. To vote on a proposal to adjourn the CECO annual meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the CECO stock issuance proposal at the time of the CECO annual meeting (the "CECO adjournment proposal"). | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| CECO Environmental Corp. | 2026-05-27 | CECO Director Election Proposal. To vote on a proposal to elect the eight directors named in the accompanying joint proxy statement/prospectus to serve until the next annual meeting of stockholders and until their successors have been duly elected and qualified (the "CECO director election proposal" | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 99.6% support |
| CECO Environmental Corp. | 2026-05-27 | CECO Stock Issuance Proposal. To vote on a proposal to approve the issuance of shares of CECO's common stock, par value $0.01 per share ("CECO common stock"), constituting the stock consideration to be issued to stockholders of Thermon Group Holdings, Inc. ("Thermon") in the first merger contemplate | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| CSG Systems International, Inc. | 2026-01-30 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to named executive officers of CSG in connection with the consummation of the merger; and | For | AGAINST — 4 of 5 Equitable funds | For | Passed (calculated), 68.9% support |
| Global Business Travel Group, Inc. | 2026-05-13 | Approval of the amendment to the Company's 2022 Equity Incentive Plan. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 97.7% support |
| Global Business Travel Group, Inc. | 2026-05-13 | Election of three Class I directors: Eric Hart | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 99.2% support |
| Global Business Travel Group, Inc. | 2026-05-13 | Election of three Class I directors: Kathleen Winters | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 99.1% support |
| PagSeguro Digital Ltd. | 2026-05-27 | Accept Financial Statements and Statutory Reports | For | ABSTAIN — 4 of 5 Equitable funds | For | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Alexandre Magnani | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Artur Gaulke Schunck | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Cleveland Prates Teixeira | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Eduardo Alcaro | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Marcia Nogueira de Mello | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Maria Carolina Ferreira Lacerda | Against | FOR — 4 of 5 Equitable funds | Against | — |
| PagSeguro Digital Ltd. | 2026-05-27 | Elect Director Maria Judith de Brito | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Paysign, Inc. | 2026-05-08 | Election of Directors: Bruce A. Mina | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Paysign, Inc. | 2026-05-08 | Election of Directors: Daniel R. Henry | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Paysign, Inc. | 2026-05-08 | Election of Directors: Jeffrey B. Newman | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Paysign, Inc. | 2026-05-08 | Election of Directors: Joan M. Herman | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Paysign, Inc. | 2026-05-08 | Election of Directors: Matthew Lanford | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Supernus Pharmaceuticals, Inc. | 2026-06-18 | to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 88.4% support |
| Supernus Pharmaceuticals, Inc. | 2026-06-18 | to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.4% support |
| ThredUp Inc. | 2026-05-20 | To elect three Class II directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dan Nova | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| WK Kellogg Co. | 2025-09-19 | The Merger Proposal - To adopt and approve the Agreement and Plan of Merger, dated as of July 10, 2025 (as it may be amended, supplemented or otherwise modified in accordance with its terms, the "Merger Agreement") by and among WK Kellogg Co, a Delaware corporation ("WK Kellog"), Ferrero Internation | Abstain | FOR — 4 of 5 Equitable funds | Against | Approved, 93.5% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Tony Xu | Withhold | FOR — 13 of 23 Equitable funds | Against | Elected, 91.2% support |
| The Coca-Cola Company | 2026-04-29 | Shareholder Vote on a shareowner proposal requesting a report on the Company's plans to increase sustainability disclosure | For | AGAINST — 12 of 21 Equitable funds | Against | Failed (calculated), 22.3% support |
| QUALCOMM Incorporated | 2026-03-17 | Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting." | For | AGAINST — 12 of 21 Equitable funds | Against | Not approved, 42.2% support |
| PepsiCo, Inc. | 2026-05-06 | Shareholder Shareholder Proposal - Report on Human Rights Oversight. | For | AGAINST — 11 of 19 Equitable funds | Against | Not approved, 16.5% support |
| Vertex Pharmaceuticals Incorporated | 2026-05-13 | Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. | For | AGAINST — 10 of 17 Equitable funds | Against | Approved, 57.0% support |
| Adobe Inc. | 2026-04-15 | Approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 10 of 17 Equitable funds | Against | Approved, 50.7% support |
| Adobe Inc. | 2026-04-15 | Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Amy Banse | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 85.5% support |
| KKR & Co. Inc. | 2026-05-21 | An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships. | Against | FOR — 10 of 17 Equitable funds | Against | — |
| Carvana Co. | 2026-05-05 | Election of Directors: Michael Maroone | Withhold | FOR — 9 of 15 Equitable funds | Against | Elected, 97.5% support |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Antoinette Bush | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 94.3% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Maverick Carter | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 89.2% support |
| Texas Pacific Land Corporation | 2025-11-06 | To elect the nine directors named in the Proxy Statement to serve until the 2026 Annual Meeting of Stockholders: Murray Stahl | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 95.8% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Luciana Borio | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 93.5% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Michael R. Minogue | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 91.1% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Timothy C. Stonesifer | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.4% support |
| PACS Group, Inc. | 2025-12-19 | To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Jacqueline Millard | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 97.0% support |
| PACS Group, Inc. | 2025-12-19 | To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Taylor Leavitt | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 97.0% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 91.3% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 90.7% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Allan Leinwand | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 97.0% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Charles Phillips | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 86.3% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Pamela Thomas-Graham | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 96.7% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie Peng | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 86.8% support |
| PTC Therapeutics, Inc. | 2026-06-02 | Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D. | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 96.1% support |
| PTC Therapeutics, Inc. | 2026-06-02 | Election of Four Class I Directors: Stephanie S. Okey, M.S. | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 94.8% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Frank J. Fertitta III | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 98.8% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Lorenzo J. Fertitta | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 98.2% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Ellen M. Lord | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 93.7% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Jeffrey N. Edwards | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 82.1% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Marc J. Walfish | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 90.9% support |
| Lumen Technologies, Inc. | 2026-05-20 | Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. | For | AGAINST — 5 of 7 Equitable funds | Against | Not approved, 47.8% support |
| Cabot Corporation | 2026-03-12 | Election of Directors: Raffiq Nathoo | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 96.9% support |
| Cabot Corporation | 2026-03-12 | Election of Directors: Sean D. Keohane | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 98.8% support |
| Cabot Corporation | 2026-03-12 | Election of Directors: Thierry Vanlancker | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 94.6% support |
| Wesbanco, Inc. | 2026-04-15 | To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025. | Against | FOR — 5 of 7 Equitable funds | Against | Approved, 64.6% support |
| Oklo Inc. | 2026-06-03 | Election of Directors: Richard W. Kinzley | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 83.3% support |
| Dyne Therapeutics, Inc. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 91.5% support |
| Dyne Therapeutics, Inc. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 87.4% support |
| Celcuity Inc. | 2026-05-14 | Elect eight directors: Polly A. Murphy | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 91.1% support |
| Celcuity Inc. | 2026-05-14 | Elect eight directors: Richard E. Buller | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 90.3% support |
| Bank of Hawaii Corporation | 2026-04-24 | Say on Pay - An advisory vote on executive compensation. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 59.8% support |
| nLIGHT, Inc. | 2026-06-05 | Election of Class II Director: Geoffrey Moore | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 55.6% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne Smith | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 86.9% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 72.9% support |
| CommScope Holding Company, Inc. | 2025-10-16 | A proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the CCS Sale Proposal (the "Adjournment Proposal"). | Abstain | FOR — 5 of 7 Equitable funds | Against | — |
| CommScope Holding Company, Inc. | 2025-10-16 | A proposal to adopt the Purchase Agreement and approve the transactions contemplated thereby, including the CCS Sale Transaction (the "CCS Sale Proposal"). | Abstain | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 100.0% support |
| Aeva Technologies, Inc. | 2026-06-18 | Election of Class II Directors: Stephen Zadesky | Withhold | FOR — 5 of 7 Equitable funds | Against | — |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt any of Proposals 2-5; and | Against | FOR — 5 of 7 Equitable funds | Against | Not approved, 31.1% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To approve the redomestication of the Company from Delaware to Texas by way of conversion; | Against | FOR — 5 of 7 Equitable funds | Against | Not approved, 45.2% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. Long | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 85.7% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Andrew W. Houston | Withhold | FOR — 13 of 24 Equitable funds | Against | Elected, 91.1% support |
| Marsh & McLennan Companies, Inc. | 2026-05-21 | Advisory (Nonbinding) Vote to Approve Named Executive Officer Compensation | Against | FOR — 12 of 22 Equitable funds | Against | Approved, 88.5% support |
| Chart Industries, Inc. | 2025-10-06 | To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger. | Against | FOR — 6 of 9 Equitable funds | Against | Approved, 95.2% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: A. R. Sanchez, Jr. | For | AGAINST — 6 of 9 Equitable funds | For | Elected, 85.9% support |
| Caterpillar, Inc. | 2026-06-10 | Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent | For | AGAINST — 11 of 20 Equitable funds | Against | Not approved, 39.5% support |
| Lam Research Corporation | 2025-11-04 | Shareholder Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. | For | AGAINST — 11 of 20 Equitable funds | Against | — |
| Arista Networks, Inc. | 2026-05-29 | Election of Directors: Greg Lavender | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 79.1% support |
| Arista Networks, Inc. | 2026-05-29 | Election of Directors: Lewis Chew | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 78.3% support |
| McDonald's Corporation | 2026-05-20 | Shareholder Advisory Vote on Shareholders' Right to Act by Written Consent. | For | AGAINST — 11 of 20 Equitable funds | Against | Failed (calculated), 41.9% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Daniel C. Smith, Ph.D. | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 95.4% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Gary M. Rodkin | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 96.3% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Glyn F. Aeppel | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 87.8% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Larry C. Glasscock | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 92.3% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Marta R. Stewart | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 98.7% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Nina P. Jones | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 99.2% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Peggy Fang Roe | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 96.6% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Randall J. Lewis | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 99.2% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Reuben S. Leibowitz | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 91.0% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Stefan M. Selig | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 98.4% support |
| Block, Inc. | 2026-06-16 | TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: JAMES MCKELVEY | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 93.8% support |
| Block, Inc. | 2026-06-16 | TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: SHAWN CARTER | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 92.4% support |
| Rockwell Automation, Inc. | 2026-02-10 | To elect as directors of Rockwell Automation, Inc. the nominees listed below: Pam Murphy | Withhold | FOR — 11 of 20 Equitable funds | Against | Elected, 91.6% support |
| Rockwell Automation, Inc. | 2026-02-10 | To elect as directors of Rockwell Automation, Inc. the nominees listed below: Robert W. Soderbery | Withhold | FOR — 11 of 20 Equitable funds | Against | Elected, 95.4% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Barry J. Nalebuff | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Cordel Robbin-Coker | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.6% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Kevin M. Ozan | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Marie Quintero-Johnson | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| Paycom Software, Inc. | 2026-05-04 | To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: J.C. Watts, Jr. | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 74.2% support |
| Paycom Software, Inc. | 2026-05-04 | To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: Sharen J. Turney | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 63.5% support |
| Domino's Pizza, Inc. | 2026-04-21 | Shareholder Shareholder proposal regarding an independent board chair requirement. | For | AGAINST — 11 of 20 Equitable funds | Against | Not approved, 39.9% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: John L. Hennessy | Against | FOR — 13 of 25 Equitable funds | Against | Elected, 85.2% support |
| Airbnb, Inc. | 2026-06-05 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Alfred Lin | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 97.3% support |
| Airbnb, Inc. | 2026-06-05 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: James Manyika | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.3% support |
| Airbnb, Inc. | 2026-06-05 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.5% support |
| Fortinet, Inc. | 2026-06-12 | To elect nine directors to serve for a term of one year until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified: Kenneth A. Goldman | Against | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 84.6% support |
| IDEXX Laboratories, Inc. | 2026-05-12 | Shareholder Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). | For | AGAINST — 9 of 16 Equitable funds | Against | — |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Alex von Furstenberg | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 92.9% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Barry Diller | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 80.2% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Beverly Anderson | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 99.0% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Chelsea Clinton | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 96.7% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Henrique Dubugras* | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.8% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: M. Moina Banerjee* | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.4% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Patricia Menendez Cambo* | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.8% support |
| The Trade Desk, Inc. | 2026-05-04 | The election of two Class I directors to hold office until our 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified: Jeff T. Green | Withhold | FOR — 8 of 14 Equitable funds | Against | Passed (calculated), 92.5% support |
| Fastenal Company | 2026-04-23 | Shareholder Shareholder proposal relating to an EEO-1 reporting disclosure policy, if properly presented at the annual meeting. | For | AGAINST or ABSTAIN — 11 of 21 Equitable funds | — | Not approved, 23.0% support |
| CBRE Group, Inc. | 2026-05-21 | Shareholder Stockholder proposal regarding our stockholders' ability to call special stockholder meetings. | For | AGAINST — 10 of 19 Equitable funds | Against | — |
| Steel Dynamics, Inc. | 2026-05-06 | Shareholder SHAREHOLDER PROPOSAL - AVOID POLITICAL SPENDING BRAND DAMAGE | For | AGAINST — 10 of 19 Equitable funds | Against | Failed (calculated), 39.3% support |
| Verisk Analytics, Inc. | 2026-05-19 | Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent. | For | AGAINST — 10 of 19 Equitable funds | Against | Approved, 53.3% support |
| UDR, Inc. | 2026-05-21 | ELECTION OF DIRECTORS: Jon A. Grove | Against | FOR — 10 of 19 Equitable funds | Against | Elected, 92.1% support |
| UDR, Inc. | 2026-05-21 | ELECTION OF DIRECTORS: Mark R. Patterson | Against | FOR — 10 of 19 Equitable funds | Against | Elected, 92.4% support |
| UDR, Inc. | 2026-05-21 | ELECTION OF DIRECTORS: Mary Ann King | Against | FOR — 10 of 19 Equitable funds | Against | Elected, 93.3% support |
| UDR, Inc. | 2026-05-21 | ELECTION OF DIRECTORS: Robert A. McNamara | Against | FOR — 10 of 19 Equitable funds | Against | Elected, 89.3% support |
| The Goldman Sachs Group, Inc. | 2026-04-29 | Shareholder Shareholder Proposal Regarding Disclosure of Energy Supply Ratio | For | AGAINST — 9 of 17 Equitable funds | Against | Not approved, 18.4% support |
| The Goldman Sachs Group, Inc. | 2026-04-29 | Shareholder Shareholder Proposal Regarding Special Shareholder Meeting Thresholds | For | AGAINST — 9 of 17 Equitable funds | Against | Failed (calculated), 36.9% support |
| Lockheed Martin Corporation | 2026-05-12 | Election of Nine Directors: Thomas J. Falk | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 88.7% support |
| KKR & Co. Inc. | 2026-05-21 | Other amendments to the Existing Charter to modernize and streamline the Existing Charter. | Against | FOR — 9 of 17 Equitable funds | Against | — |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Baiju Bhatt | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.7% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Christopher Payne | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.7% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Dara Treseder | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 95.0% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: John Hegeman | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.7% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Jonathan Rubinstein | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 90.7% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Meyer Malka | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.7% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Paula Loop | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.6% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Robert Zoellick | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 95.0% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Susan Segal | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 99.1% support |
| Robinhood Markets, Inc. | 2026-06-02 | To elect to the Board of Directors the ten director nominees named in the proxy statement: Vladimir Tenev | Against | FOR — 9 of 17 Equitable funds | Against | Passed (calculated), 98.9% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Brian Leach | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.1% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Gary Cohn | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 97.0% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James Belardi | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.6% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James Zelter | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.6% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Jessica Bibliowicz | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.5% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Kerry Murphy Healey | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.3% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Lynn Swann | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 98.3% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc Beilinson | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 96.9% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc Rowan | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 98.3% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Mitra Hormozi | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 98.4% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Pamela Joyner | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.3% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Patrick Toomey | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.5% support |
| Apollo Global Management, Inc. | 2026-06-08 | The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Scott Kleinman | Against | FOR — 9 of 17 Equitable funds | Against | Elected, 99.6% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Michelle Zatlyn | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 99.9% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Sasan Goodarzi | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 99.5% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Scott Belsky | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 99.9% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Scott Farquhar | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 96.9% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Steven Sordello | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 99.8% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Brian Armstrong | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 97.9% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Chris Lehane | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 99.8% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Christa Davies | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 99.9% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Fred Wilson | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 99.3% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Gokul Rajaram | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 96.1% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Kelly A. Kramer | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 99.4% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Marc L. Andreessen | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 97.1% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Tobias Lutke | Withhold | FOR — 9 of 17 Equitable funds | Against | Elected, 99.7% support |
| Roblox Corporation | 2026-05-28 | Election of Class II Directors: Gregory Baszucki | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 93.7% support |
| Affirm Holdings, Inc. | 2025-12-15 | To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Christa S. Quarles | For | AGAINST — 5 of 8 Equitable funds | Against | Elected, 96.0% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Anna Reilly | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 92.4% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Elizabeth Thompson | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 92.6% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Kevin P. Reilly, Jr. | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 92.3% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Marshall A. Loeb | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 91.4% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Mitch Landrieu | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 99.8% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Nancy Fletcher | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 99.6% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Thomas V. Reifenheiser | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 89.9% support |
| Lamar Advertising Company | 2026-05-14 | Election of directors: Wendell Reilly | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 92.4% support |
| Nextracker Inc. | 2025-08-18 | The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Brandi Thomas | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 96.5% support |
| Nextracker Inc. | 2025-08-18 | The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey Guldner | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 74.3% support |
| BridgeBio Pharma, Inc. | 2026-06-22 | To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly ele | Withhold | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 97.3% support |
| BridgeBio Pharma, Inc. | 2026-06-22 | To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly ele | Withhold | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 95.0% support |
| BridgeBio Pharma, Inc. | 2026-06-22 | To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly ele | Withhold | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 80.1% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFA | Withhold | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 93.6% support |
| Hecla Mining Company | 2026-05-21 | ELECTION OF TWO CLASS I DIRECTORS: Dean R. Gehring | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 96.3% support |
| Granite Construction Incorporated | 2026-06-04 | Election of Directors: Carlos M. Hernandez | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 96.1% support |
| Granite Construction Incorporated | 2026-06-04 | Election of Directors: Celeste B. Mastin | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 94.6% support |
| EnerSys | 2025-07-31 | Elect three (3) Class III director nominees: Howard I. Hoffen | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 86.9% support |
| EnerSys | 2025-07-31 | Elect three (3) Class III director nominees: Ronald P. Vargo | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 96.4% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Frank M. Jaehnert | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 83.7% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Jerome J. Lande | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 96.0% support |
| Itron, Inc. | 2026-05-07 | Election of Directors: Sanjay Mirchandani | Against | FOR — 5 of 8 Equitable funds | Against | Elected, 96.5% support |
| ICU Medical, Inc. | 2026-05-13 | Shareholder To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. | For | AGAINST — 6 of 10 Equitable funds | Against | Not approved, 40.7% support |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Che-Wei Lin | Withhold | FOR — 5 of 8 Equitable funds | Against | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | To approve the 2026 equity incentive plan. | Against | FOR — 5 of 8 Equitable funds | Against | Passed (calculated), 90.2% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 73.5% support |
| Nuvalent, Inc. | 2026-06-16 | Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. | Withhold | FOR — 5 of 8 Equitable funds | Against | Elected, 81.5% support |
| Carvana Co. | 2026-05-05 | Election of Directors: Neha Parikh | Withhold | FOR — 8 of 15 Equitable funds | Against | Elected, 95.0% support |
| Rocket Companies, Inc. | 2026-06-10 | Election of Class III Directors: Suzanne Shank | For | WITHHOLD — 3 of 4 Equitable funds | For | Passed (calculated), 89.6% support |
| Astera Labs, Inc. | 2026-06-04 | To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Craig Barratt | For | WITHHOLD — 3 of 4 Equitable funds | Against | Elected, 83.8% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Catherine Johnson | For | WITHHOLD — 4 of 6 Equitable funds | Against | Elected, 97.4% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Daniel Maguire | For | WITHHOLD — 4 of 6 Equitable funds | Against | Elected, 97.4% support |
| Tradeweb Markets Inc. | 2026-05-19 | Election of Directors: Scott Ganeles | For | WITHHOLD — 4 of 6 Equitable funds | Against | Elected, 96.9% support |
| Alnylam Pharmaceuticals, Inc. | 2026-05-20 | To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D. | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 99.6% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | Election of Class II Directors: J. Kristofer Galashan | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 76.4% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | Election of Class II Directors: Jennifer Pomerantz | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 77.4% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | Election of Class II Directors: Joel Alsfine | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 94.8% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | Election of Class II Directors: Jonathan Coslet | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 79.6% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | Election of Class II Directors: Stuart Lasher | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 89.4% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander Plouffe | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.5% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Laura Lang | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.9% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha Sankaran | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.7% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Vanessa Ames Wittman | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.8% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen III | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 96.9% support |
| TG Therapeutics, Inc. | 2026-06-11 | Election of Directors: Laurence Charney | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 83.7% support |
| TG Therapeutics, Inc. | 2026-06-11 | Election of Directors: Michael S. Weiss | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 88.6% support |
| PACS Group, Inc. | 2026-06-10 | To elect Evelyn Dilsaver and Mark Hancock as Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Evelyn Dilsaver | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 95.0% support |
| Amneal Pharmaceuticals, Inc. | 2026-05-06 | Election of Directors: Paul Meister | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 87.5% support |
| Casella Waste Systems, Inc. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle Green | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 66.5% support |
| Casella Waste Systems, Inc. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Joseph G. Doody | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 89.9% support |
| Casella Waste Systems, Inc. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Michael L. Battles | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 73.4% support |
| PJT Partners Inc. | 2026-06-18 | To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): K. Don Cornwell | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 97.8% support |
| PJT Partners Inc. | 2026-06-18 | To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): Thomas M. Ryan | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 84.6% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Andrew T. D'Amico | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Claudio Tuozzolo | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: James F. Schmidt | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.1% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jason L. Carlson | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 93.7% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: John Shen | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.7% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Michael S. McNamara | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.3% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Patrizio Vinciarelli | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.0% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Philip D. Davies | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.5% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Samuel J. Anderson | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.4% support |
| Vicor Corporation | 2026-06-19 | To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Zmira Lavie | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.7% support |
| RadNet, Inc. | 2026-06-02 | Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Laura P. Jacobs | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 87.4% support |
| Balchem Corporation | 2026-06-18 | Election of Directors: Daniel Knutson | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 98.4% support |
| Balchem Corporation | 2026-06-18 | Election of Directors: David Fischer | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 93.1% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Angela Courtin | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 76.3% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Manuel A. Diaz | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.5% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Mark Carleton | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.7% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Michael J. Dominguez | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 98.7% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Nicolas Brien | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 99.6% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Peter Mathes | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 98.7% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Susan M. Tolson | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 66.4% support |
| Varonis Systems, Inc. | 2026-06-01 | To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Avrohom J. Kess | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 91.1% support |
| Varonis Systems, Inc. | 2026-06-01 | To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Thomas F. Mendoza | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 94.4% support |
| Waystar Holding Corp. | 2026-06-01 | Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John Driscoll | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 86.5% support |
| Concentra Group Holdings Parent, Inc. | 2026-04-30 | Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 81.8% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 97.6% support |
| Merit Medical Systems, Inc. | 2026-05-13 | The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 97.8% support |
| Joby Aviation, Inc. | 2026-06-02 | Election of Directors: To be elected for terms expiring in 2029: Halimah DeLaine Prado | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 92.9% support |
| Joby Aviation, Inc. | 2026-06-02 | Election of Directors: To be elected for terms expiring in 2029: Laura Wright | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 98.4% support |
| Joby Aviation, Inc. | 2026-06-02 | Election of Directors: To be elected for terms expiring in 2029: Paul Sciarra | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 98.9% support |
| Axos Financial, Inc. | 2025-11-13 | Election of Directors: James J. Court | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 62.4% support |
| Axos Financial, Inc. | 2025-11-13 | Election of Directors: James S. Argalas | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 95.7% support |
| Axos Financial, Inc. | 2025-11-13 | Election of Directors: Roque A. Santi | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 97.1% support |
| Axos Financial, Inc. | 2025-11-13 | Election of Directors: Stefani D. Carter | Withhold | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 62.8% support |
| Axos Financial, Inc. | 2025-11-13 | To approve an amendment to the Amended and Restated 2014 Stock Incentive Plan. | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 63.1% support |
| Axos Financial, Inc. | 2025-11-13 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in the proxy statement. | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 58.7% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: David A. Greenblatt | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 89.9% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: Julia W. Sze | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 97.1% support |
| Cavco Industries, Inc. | 2025-07-29 | Election of Directors: Richard A. Kerley | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 95.6% support |
| Travere Therapeutics, Inc. | 2026-05-19 | To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy Baynes | For | WITHHOLD — 4 of 6 Equitable funds | For | Elected, 87.7% support |
| Cinemark Holdings, Inc. | 2026-05-14 | 4 wordings Election of Class I directors, each for a term that expires in 2029: Nancy Loewe | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 94.3% support |
| The Baldwin Insurance Group, Inc. | 2026-06-04 | Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn Shook | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 82.2% support |
| The Baldwin Insurance Group, Inc. | 2026-06-04 | Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Lowry Baldwin | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 95.7% support |
| The Baldwin Insurance Group, Inc. | 2026-06-04 | Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sathish Muthukrishnan | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 99.0% support |
| The Baldwin Insurance Group, Inc. | 2026-06-04 | Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sunita Parasuraman | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 98.9% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: David Pearson | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 95.3% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: Doug Knopper | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 92.8% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: Paul Caine | Against | FOR — 3 of 4 Equitable funds | Against | Elected, 95.0% support |
| First Advantage Corporation | 2026-06-05 | To elect three Class II director nominees listed in this Proxy Statement: Bridgett R. Price | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 93.7% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Election of Directors: A. James Teague | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 96.7% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Election of Directors: Edgar R. Giesinger | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 78.9% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Election of Directors: William A. Zartler | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 96.6% support |
| BancFirst Corporation | 2026-05-28 | Election of Directors: David R. Harlow | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 85.0% support |
| Cohen & Steers, Inc. | 2026-04-30 | Election of Directors: Edmond D. Villani | For | AGAINST — 4 of 6 Equitable funds | For | Passed (calculated), 87.9% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Denise Knouse-Snyder | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 94.4% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: F. Eric Nelson, Jr. | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 91.3% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: John L. Bookmyer | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.6% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Louis M. Altman | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.6% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Todd F. Clossin | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.2% support |
| Wesbanco, Inc. | 2026-04-15 | To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (b) For a term of one (1) year expiring at the annual stockholders meeting in 2027: Joseph R. Robinson | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.7% support |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Elizabeth Crain | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.7% support |
| Core Scientific, Inc. | 2026-05-12 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 4 of 6 Equitable funds | Against | Approved, 63.7% support |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: John M. Albertine | Against | FOR — 3 of 4 Equitable funds | Against | — |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. Leonard | Against | FOR — 3 of 4 Equitable funds | Against | — |
| HNI Corporation | 2025-12-05 | Proposal to approve the issuance of shares of HNI common stock to holders of Steelcase common stock pursuant to the Merger Agreement (the "HNI common stock issuance proposal"). | Abstain | FOR — 4 of 6 Equitable funds | Against | Approved, 96.9% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To approve, on a non-binding advisory basis, the Company's executive compensation. | For | AGAINST — 3 of 4 Equitable funds | For | Approved, 87.9% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To elect Directors - Nominees: R. W. Cardin | For | WITHHOLD — 3 of 4 Equitable funds | For | Elected, 91.0% support |
| Arcutis Biotherapeutics, Inc. | 2026-06-05 | 2 wordings Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 67.4% support |
| Oceaneering International, Inc. | 2026-05-15 | Election of Class I Directors: Jon Erik Reinhardsen | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 81.0% support |
| Oceaneering International, Inc. | 2026-05-15 | Election of Class I Directors: Reema Poddar | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 91.8% support |
| Oceaneering International, Inc. | 2026-05-15 | Election of Class I Directors: William B. Berry | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 96.9% support |
| The GEO Group, Inc. | 2026-04-28 | Advisory vote to approve named executive officer compensation. | For | AGAINST — 3 of 4 Equitable funds | For | Approved, 71.6% support |
| The GEO Group, Inc. | 2026-04-28 | Election of Directors: Jack Brewer | For | AGAINST — 3 of 4 Equitable funds | For | Elected, 78.5% support |
| Lemonade, Inc. | 2026-06-03 | Election of Class III Directors: Debra Schwartz | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 87.6% support |
| Group 1 Automotive, Inc. | 2026-05-12 | Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. | For | AGAINST — 3 of 4 Equitable funds | Against | Not approved, 25.3% support |
| Celcuity Inc. | 2026-05-14 | To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. | For | AGAINST — 4 of 6 Equitable funds | For | — |
| TriNet Group, Inc. | 2026-05-27 | Election of Directors: David C. Hodgson | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 96.2% support |
| TriNet Group, Inc. | 2026-05-27 | Election of Directors: Jacqueline Kosecoff | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 98.7% support |
| TriNet Group, Inc. | 2026-05-27 | Election of Directors: Michael J. Angelakis | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 97.5% support |
| Archer Aviation Inc. | 2026-06-26 | Approval of the redomestication of the Company from Delaware to Texas by conversion. | Against | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 84.0% support |
| Archer Aviation Inc. | 2026-06-26 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Against | FOR — 3 of 4 Equitable funds | Against | Approved, 82.0% support |
| Archer Aviation Inc. | 2026-06-26 | Election of Class II Directors: Barbara Pilarski | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 87.0% support |
| Archer Aviation Inc. | 2026-06-26 | Election of Class II Directors: Maria Pinelli | Withhold | FOR — 3 of 4 Equitable funds | Against | Passed (calculated), 96.6% support |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: William F. Ballhaus | Against | FOR — 4 of 6 Equitable funds | Against | Elected, 82.6% support |
| Worthington Enterprises, Inc. | 2025-09-23 | Approve the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 91.7% support |
| Worthington Enterprises, Inc. | 2025-09-23 | Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Billy R. Vickers | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 96.1% support |
| Worthington Enterprises, Inc. | 2025-09-23 | Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: David P. Blom | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 90.4% support |
| Worthington Enterprises, Inc. | 2025-09-23 | Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Kerrii B. Anderson | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 97.7% support |
| Worthington Enterprises, Inc. | 2025-09-23 | Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Paul G. Heller | Against | FOR — 4 of 6 Equitable funds | Against | Passed (calculated), 99.5% support |
| The Marzetti Company | 2025-11-19 | To elect four directors, each for a term that expires in 2028: Alan F. Harris | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 92.1% support |
| The Marzetti Company | 2025-11-19 | To elect four directors, each for a term that expires in 2028: Barbara L. Braiser | Withhold | FOR — 4 of 6 Equitable funds | Against | — |
| The Marzetti Company | 2025-11-19 | To elect four directors, each for a term that expires in 2028: David A. Ciesinski | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 99.1% support |
| The Marzetti Company | 2025-11-19 | To elect four directors, each for a term that expires in 2028: Elliot K. Fullen | Withhold | FOR — 4 of 6 Equitable funds | Against | Elected, 97.6% support |
| Tootsie Roll Industries, Inc. | 2026-05-06 | Election of Directors: Ellen R. Gordon | Withhold | FOR — 3 of 4 Equitable funds | Against | Elected, 98.5% support |
250 more in the CSV.
Download all 750 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.2% of this fund’s 8,110 such votes could be given a sector; the other 306 (3.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 1,799 | 78 | 4.3% |
| Technology | 1,493 | 63 | 4.2% |
| Health Care | 1,367 | 15 | 1.1% |
| Finance | 1,101 | 17 | 1.5% |
| Industrials | 1,009 | 21 | 2.1% |
| Real Estate | 260 | 0 | 0.0% |
| Consumer Staples | 168 | 8 | 4.8% |
| Utilities | 165 | 1 | 0.6% |
| Energy | 150 | 1 | 0.7% |
| Miscellaneous | 140 | 0 | 0.0% |
| Basic Materials | 76 | 0 | 0.0% |
| Telecommunications | 76 | 5 | 6.6% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,727 | 25 |
| Say-on-Pay | 882 | 4 |
| Audit-related | 851 | 0 |
| Corporate Governance | 284 | 78 |
| Compensation | 281 | 4 |
| Capital Structure | 85 | 0 |
| Extraordinary Transactions | 57 | 0 |
| Other Social Issues | 44 | 37 |
| Environment or Climate | 33 | 32 |
| Shareholder Rights and Defenses | 33 | 14 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| NVIDIA Corporation | June 24, 2026 | $160M | 16 | 4 |
| Apple Inc. | February 24, 2026 | $125M | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $114M | 21 | 4 |
| Meta Platforms, Inc. | May 27, 2026 | $101M | 22 | 7 |
| Amazon.com, Inc. | May 20, 2026 | $80M | 17 | 4 |
| Alphabet Inc. | June 5, 2026 | $66M | 23 | 7 |
| Broadcom Inc. | April 20, 2026 | $57M | 10 | 0 |
| Eli Lilly and Company | May 4, 2026 | $40M | 10 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding dual class capital structure. Shareholder proposal | For | Against |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding equal shareholder voting Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.
8,295 ballot items at 906 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Multimanager Aggressive Equity Portfolio voted at 906 shareholder meetings of 867 companies, on 8,295 ballot items in all. Where management made a recommendation, the fund followed it on 97.0% of the items and voted against it 209 times. Its most frequent area of disagreement was corporate governance (78 of its votes against management). It voted FOR 33.7% of the 184 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Equitable's funds as a whole (85.1% against 92.5%). It voted differently from most Equitable funds on 750 items. 3 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.